Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Sampson

Showing results (201-210 of 230) with videos related to

Pageof 23
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2014
Pooling prospective studies to investigate the etiology of second cancersAmanda Black, Todd M Gibson, Meredith S Shiels, et al.
Radiation Research|December 4, 2019
Comparison of Radiation Dose Reconstruction Methods to Investigate Late Adverse Effects of Radiotherapy for Childhood Cancer: A Report from the Childhood Cancer Survivor StudySara J Schonfeld, Rebecca M Howell, Susan A Smith, et al.
NPJ Breast Cancer|September 23, 2020
Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breastClara Bodelon, Hannah Oh, Andriy Derkach, et al.
JCO Precision Oncology|November 21, 2022
Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in <i>CDKN2A</i> and Pancreatic CancerEsteban Astiazaran-Symonds, Cole Graham, Jung Kim, et al.
Journal of the National Cancer Institute. Monographs|September 1, 2014
Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectPaige M Bracci, Yolanda Benavente, Jennifer J Turner, et al.
Vaccine|July 14, 2024
Meeting report: Considerations for trial design and endpoints in licensing therapeutic HPV16/18 vaccines to prevent cervical cancerPeter M Dull, Sharon L Achilles, Rafi Ahmed, et al.
Vaccine|December 3, 2021
Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trialCarolina Porras, Joshua N Sampson, Rolando Herrero, et al.
Human Genetics|July 25, 2016
Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutationsXiaohong R Yang, Melissa Rotunno, Yanzi Xiao, et al.
Nature Cancer|October 19, 2020
Age-associated mitochondrial DNA mutations cause metabolic remodelling that contributes to accelerated intestinal tumorigenesisAnna Lm Smith, Julia C Whitehall, Carla Bradshaw, et al.
JCO Precision Oncology|September 14, 2020
Subsequent Neoplasm Risk Associated With Rare Variants in DNA Damage Response and Clinical Radiation Sensitivity Syndrome Genes in the Childhood Cancer Survivor StudyLindsay M Morton, Danielle M Karyadi, Stephen W Hartley, et al.
Pageof 23

Showing results (201-210 of 230) with videos related to

Sort By:
Pageof 23
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2014
Pooling prospective studies to investigate the etiology of second cancersAmanda Black, Todd M Gibson, Meredith S Shiels, et al.
Radiation Research|December 4, 2019
Comparison of Radiation Dose Reconstruction Methods to Investigate Late Adverse Effects of Radiotherapy for Childhood Cancer: A Report from the Childhood Cancer Survivor StudySara J Schonfeld, Rebecca M Howell, Susan A Smith, et al.
NPJ Breast Cancer|September 23, 2020
Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breastClara Bodelon, Hannah Oh, Andriy Derkach, et al.
JCO Precision Oncology|November 21, 2022
Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in <i>CDKN2A</i> and Pancreatic CancerEsteban Astiazaran-Symonds, Cole Graham, Jung Kim, et al.
Journal of the National Cancer Institute. Monographs|September 1, 2014
Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectPaige M Bracci, Yolanda Benavente, Jennifer J Turner, et al.
Vaccine|July 14, 2024
Meeting report: Considerations for trial design and endpoints in licensing therapeutic HPV16/18 vaccines to prevent cervical cancerPeter M Dull, Sharon L Achilles, Rafi Ahmed, et al.
Vaccine|December 3, 2021
Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trialCarolina Porras, Joshua N Sampson, Rolando Herrero, et al.
Human Genetics|July 25, 2016
Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutationsXiaohong R Yang, Melissa Rotunno, Yanzi Xiao, et al.
Nature Cancer|October 19, 2020
Age-associated mitochondrial DNA mutations cause metabolic remodelling that contributes to accelerated intestinal tumorigenesisAnna Lm Smith, Julia C Whitehall, Carla Bradshaw, et al.
JCO Precision Oncology|September 14, 2020
Subsequent Neoplasm Risk Associated With Rare Variants in DNA Damage Response and Clinical Radiation Sensitivity Syndrome Genes in the Childhood Cancer Survivor StudyLindsay M Morton, Danielle M Karyadi, Stephen W Hartley, et al.
Pageof 23